2.86

1.38% -0.04

Mdxhealth Sa (MDXH)

Overview News Price History Discussions Forecast

Mdxhealth Sa stock is traded at $2.86, with a volume of 270.20K. It is down -1.38% in the last 24 hours and down -18.98% over the past month. MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Previous Close:

$2.90

Open:

$3.11

24h Volume:

270.20K

Relative Volume:

1.98

Market Cap:

$146.90M

Revenue:

$107.88M

Net Income/Loss:

$-33.52M

P/E Ratio:

-4.2898

EPS:

-0.6667

Net Cash Flow:

$-11.94M

1W Performance:

-12.54%

1M Performance:

-18.98%

6M Performance:

-33.49%

1Y Performance:

+82.17%

1-Day Range:

$2.71

$3.15

1-Week Range:

$2.71

$3.29

52-Week Range:

$1.36

$5.33

Mdxhealth Sa Stock (MDXH) Company Profile

Name

Mdxhealth Sa

Sector

Healthcare (1114)

Industry

Diagnostics & Research (51)

Phone

Address

Employee

312

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

MDXH's Discussions on Twitter

Compare MDXH vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXH Mdxhealth Sa	2.86	148.96M	107.88M	-33.52M	-11.94M	-0.6667
TMO Thermo Fisher Scientific Inc	490.77	182.31B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	187.15	132.34B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	575.72	45.84B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	112.98	31.93B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	302.32	29.66B	3.17B	642.63M	516.49M	10.77

Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-17-25	Initiated	Craig Hallum	Buy
Oct-31-24	Initiated	Lake Street	Buy
May-31-23	Initiated	TD Cowen	Outperform
Jul-18-22	Resumed	Oppenheimer	Outperform

Mdxhealth Sa Stock (MDXH) Latest News

Mar 25, 2026

MDxHealth (NASDAQ: MDXH) director reports 10,000-share option grant - Stock Titan

Mar 18, 2026

MVM Partners (MDXH) discloses indirect stake of 4.7M MDxHealth shares - Stock Titan

Mar 18, 2026

MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 18, 2026

Mar 16, 2026

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 - The Manila Times

Mar 16, 2026

Gene test flags prostate cancer patients who may avoid aggressive treatment - Stock Titan

Mar 16, 2026

Mar 14, 2026

MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat

Mar 14, 2026

Mar 13, 2026

MDxHealth SA Stock (ISIN: US55278X1072) Gains Momentum on Prostate Cancer Test Momentum - AD HOC NEWS

Mar 13, 2026

Mar 06, 2026

Mdxhealth Earnings Call Highlights Fast Growth, Rising Costs - TipRanks

Mar 06, 2026

MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics - MSN

Mar 06, 2026

How is MDxHealth SA managing supply chain issuesJuly 2025 Recap & Low Drawdown Investment Strategies - baoquankhu1.vn

Mar 06, 2026

Mar 04, 2026

MDXHMdxhealth Sa Latest Stock News & Market Updates - Stock Titan

Mar 04, 2026

BTIG reiterates MDxHealth stock rating on strong volume growth By Investing.com - Investing.com Canada

Mar 04, 2026

BTIG reiterates MDxHealth stock rating on strong volume growth - Investing.com

Mar 04, 2026